CD8A and glioblastoma: As detailed above, CD8+ cytotoxic T cells, CD4+ effector T cells, and regulatory T cells each contribute uniquely to the immune dynamics in GBM, with their clinical relevance increasingly linked to their functional state and spatial distribution.